Epivir
® (
lamivudine) is a prescription medication used to treat
AIDS and
HIV. It is approved only to be combined with other medications for the treatment of HIV. It is not approved to be used by itself. Epivir-HBV
® (which also contains lamivudine) is approved to treat chronic
hepatitis B.
The medication is made by GlaxoSmithKline.
Epivir belongs to group of medications known as nucleoside reverse transcriptase inhibitors (NRTIs).
NRTI medications work by blocking a process that the HIV and hepatitis B viruses need in order to multiply.
HIV (the human immunodeficiency virus) is the virus that is responsible for AIDS, and HBV (the
hepatitis B virus) is responsible for hepatitis B infection. Like other viruses, HIV and HBV must use a person's own cells to reproduce. However, HIV and HBV are different from many other viruses because they must first convert their genetic material from RNA to DNA. It is the DNA genes that allow HIV and HBV to multiply.
HIV and HBV convert their genetic material into DNA by using a special protein called the reverse transcriptase enzyme. To create DNA, this enzyme uses several different protein building blocks.
Epivir works by tricking reverse transcriptase into thinking it is one of these protein building blocks. However, it is just different enough that when used to create DNA, Epivir actually stops the DNA from being made. Without DNA, HIV and HBV cannot multiply. It is important to understand that this drug is not a cure for HIV, AIDS, or hepatitis B.
